(PRWEB) April 24, 2013
The US Drug Watchdog is now saying, "After talking to over a thousand women in most US states who are victims of a transvaginal mesh failure all that we can say is it is a stunning tragedy, with no easy fixes, because numerous repair surgeries could be involved. We especially want to hear from transvaginal mesh failure victims nationwide, who have severe medical complications such as erosion in the hopes we can suggest national caliber women attorneys, who are passionate about helping victims." According to the US FDA, "Transvaginal mesh failures are causing complications in patients such as erosion, or serious infections. Women who experience transvaginal mesh failure may need to have numerous corrective surgeries, IV therapy, blood transfusions and drainage of hematomas or abscesses." The US Drug Watchdog has dramatically expanded their national initiative designed to help women victims of transvaginal mesh failure, who are now severely injured by these types of medical products. For more information women, who are victims of a transvaginal mesh failure are urged to contact the US Drug Watchdog anytime at 866-714-6466.
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implant failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh failure. If you have a friend, or loved one who is a recipient of a transvaginal mesh type product that has already failed or is showing symptoms of a failure, please have them call us at 866-714-6466. This is a nationwide problem impacting women in all states, and we want to make certain all women, who are transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com.
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10650788.htm.
Copyright©2012 Vocus, Inc.
All rights reserved